News for LifeMD, Inc. (LFMD)

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

LifeMD, Inc. (NASDAQ:LFMD) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief Executive...

**media[562511]**

LifeMD (LFMD) delivered earnings and revenue surprises of 66.67% and 12.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.

LifeMD (LFMD) Q4 earnings report is on March 10th. Analysts expect $0.14 EPS (-6.7% Y/Y) & $57.43M revenue (+28% Y/Y).

LifeMD Inc (LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue is $57.38 million, and the earnings are e

Healthcare services companies LifeMD (LFMD) and Teladoc Health (TDOC) announced partnerships with Eli Lilly's (LLY) direct-to-consumer platform.

**media[559106]**

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. ( LFMD), a leading provider of virtual primary care services, today announced its participation in t

NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. ( LFMD), a leading provider of virtual primary care services, announces that it will report financial

[url="]Medifast[/url] (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, [url="]OPTA[/url][url="]VIA®

LifeMD generates solid revenue growth but trades at a 1.08x sales multiple. Find out why LFMD stock’s preferreds offer attractive yields with dilution concerns.

**media[526205]**

LifeMD CEO Justin Schreiber sells $129,667 in stock

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

**media[500239]**

NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. ( LFMD), a leading provider of virtual primary care services, today announced that its Board of Direc